No takes yet. Share an insight, caveat, or question.
Review summarizes RET and RAS mutations in hereditary and sporadic medullary thyroid cancer, indicating personalized therapy options.
Chevais et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: